TRINETRA › Sectors › Healthcare
Sai Parenterals Limited (SAIPARENT) — share price, P/E and fundamentals
Sai Parenterals Limited (NSE: SAIPARENT) closed at ₹517.00 on 30 Oct 2026, against a 52-week range of ₹400.00 – ₹706.00.
In the quarter ended 30 Jun 2026 (consolidated, filed 11 Aug 2026) it reported revenue of ₹179 cr and net profit of ₹8 cr, a 4.4% net margin.
No trailing P/E is published: only 3 filed quarters available — a trailing twelve months needs 4.
From the balance sheet dated 31 Mar 2026: return on equity 6.5%, ROCE 9.0%, debt-to-equity 0.65.
Against 66 Healthcare peers on NSE: Net margin higher than 14% of 64 sector peers; PBT margin higher than 11% of 64 sector peers; ROE higher than 14% of 64 sector peers.
Key figures
| Last close | ₹517.00 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | +2.1% / +6.7% / — |
| 52-week low – high | ₹400.00 – ₹706.00 |
| Market capitalisation | ₹2,284 cr |
| Quarter revenue | ₹179 cr |
| Quarter net profit | ₹8 cr |
| Net margin | 4.4% |
| Return on equity | 6.5% |
| ROCE | 9.0% |
| Debt / equity | 0.65 |
| Current ratio | 1.44 |
| Free cash flow | ₹75 cr |
| Average daily turnover (50 days) | ₹3.7 cr |
Against Healthcare peers
| Metric | SAIPARENT | Peer median | Percentile |
|---|---|---|---|
| Net margin | 4.43 | 12.89 | 14 |
| PBT margin | 5.48 | 17.68 | 11 |
| ROE | 6.46 | 13.87 | 14 |
| ROCE | 8.99 | 17.26 | 17 |
| Debt / equity | 0.65 | 0.11 | 92 |
| Cash conversion | 6.53 | 1.25 | 98 |
Questions
What were Sai Parenterals Limited's latest quarterly results?
For the quarter ended 30 Jun 2026, Sai Parenterals Limited reported revenue of ₹179 cr and net profit of ₹8 cr (consolidated), filed with the exchange on 11 Aug 2026.
What is Sai Parenterals Limited's ROE?
Return on equity is 6.5% based on the balance sheet dated 31 Mar 2026.
Does Sai Parenterals Limited have debt?
Debt-to-equity is 0.65 on the balance sheet dated 31 Mar 2026.
What is SAIPARENT's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, SAIPARENT traded between ₹400.00 and ₹706.00.
Other Healthcare stocks
- Sun Pharmaceutical Industries Limited (SUNPHARMA)
- Divi's Laboratories Limited (DIVISLAB)
- Torrent Pharmaceuticals Limited (TORNTPHARM)
- Laurus Labs Limited (LAURUSLABS)
- Zydus Lifesciences Limited (ZYDUSLIFE)
- Apollo Hospitals Enterprise Limited (APOLLOHOSP)
- Dr. Reddy's Laboratories Limited (DRREDDY)
- Cipla Limited (CIPLA)
- Mankind Pharma Limited (MANKIND)
- Aurobindo Pharma Limited (AUROPHARMA)
- Lupin Limited (LUPIN)
- Max Healthcare Institute Limited (MAXHEALTH)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Jun 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.